Company intelligence / Profile preview
Virtici
Seattle, Washington, United Statesvirtici.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Virtici establishes and incubates early therapeutic programs focused on immune-mediated, metabolic, infectious, and neurological diseases. Several pipeline candidates are at preclinical development stage, generating data and seeking or enabling further progression to clinical trial stage[1][2].
- Therapeutic areas
- NeurologyEndocrinologyOther
- Modalities
- Fusion proteinBispecific monoclonal antibodyRecombinant protein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Celdara MedicalCritical Path Institute (C-Path)NIH ASCEND Hub
Beyond the preview
Go deeper on Virtici.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virtici.